Defilade Capital Management, L.P.
An institutional investment manager in EMERYVILLE, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 2088557.
- Reported value$746.9m
- Positions39
Holdings: 39 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ELI Lilly & CoLLY | COM | 532457108 | 46.9 | 6.3% | 39,086 | Added+18,390 | |
| Pfizer IncPFE | COM | 717081103 | 42.7 | 5.7% | 1,771,743 | Added+307,614 | |
| Veeva Sys IncVEEV | CL A COM | 922475108 | 42.0 | 5.6% | 236,709 | New+236,709 | |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 39.0 | 5.2% | 682,005 | New+682,005 | |
| PTC Therapeutics IncPTCT | COM | 69366J200 | 35.4 | 4.7% | 433,699 | Added+57,534 | |
| Baxter International IncBAX | COM | 071813109 | 31.1 | 4.2% | 1,459,380 | New+1,459,380 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 30.0 | 4.0% | 281,838 | Added+86,929 | |
| Zimmer Biomet Holdings IncZBH | COM | 98956P102 | 27.3 | 3.7% | 317,426 | Reduced−261,735 | |
| Insulet CorpPODD | COM | 45784P101 | 26.9 | 3.6% | 176,932 | New+176,932 | |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 26.0 | 3.5% | 51,934 | New+51,934 | |
| Abbott LaboratoriesABT | COM | 002824100 | 25.9 | 3.5% | 285,778 | New+285,778 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 25.3 | 3.4% | 94,843 | New+94,843 | |
| Solventum CorpSOLV | COM SHS | 83444M101 | 24.4 | 3.3% | 316,454 | New+316,454 | |
| Medtronic plc | SHS | G5960L103 | 23.7 | 3.2% | 303,301 | New+303,301 | |
| Elanco Animal Health IncELAN | COM | 28414H103 | 21.3 | 2.8% | 864,080 | Reduced−67,041 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 20.3 | 2.7% | 546,848 | New+546,848 | |
| Envista Holdings CorporationNVST | COM | 29415F104 | 19.1 | 2.6% | 726,108 | New+726,108 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 15.5 | 2.1% | 82,827 | Reduced−233,145 | |
| ICU Med IncICUI | COM | 44930G107 | 15.5 | 2.1% | 105,700 | Reduced−148,591 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 15.2 | 2.0% | 393,441 | Added+40,851 | |
| Lantheus Holdings IncLNTH | COM | 516544103 | 14.7 | 2.0% | 132,662 | Reduced−116,739 | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 14.6 | 2.0% | 1,490,286 | Added+2,641 | |
| Eledon Pharmaceuticals IncELDN | COM | 28617K101 | 13.9 | 1.9% | 3,525,338 | Reduced−38,789 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 12.0 | 1.6% | 376,870 | New+376,870 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 11.6 | 1.5% | 924,758 | Reduced−579,778 | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 11.3 | 1.5% | 1,047,690 | Added+204,762 | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 11.2 | 1.5% | 3,670,135 | New+3,670,135 | |
| Globus Med IncGMED | CL A | 379577208 | 11.0 | 1.5% | 139,637 | Reduced−214,713 | |
| Enovis CorporationENOV | COM | 194014502 | 11.0 | 1.5% | 531,945 | New+531,945 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 10.5 | 1.4% | 793,145 | Added+114,556 | |
| Teleflex IncorporatedTFX | COM | 879369106 | 10.2 | 1.4% | 80,118 | New+80,118 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 10.1 | 1.3% | 391,866 | Reduced−968,103 | |
| Glaukos CorpGKOS | COM | 377322102 | 9.3 | 1.2% | 66,519 | New+66,519 | |
| Staar Surgical CoSTAA | COM PAR $0.01 | 852312305 | 9.2 | 1.2% | 322,126 | New+322,126 | |
| Pacs Group IncPACS | COM SHS | 69380Q107 | 9.2 | 1.2% | 215,675 | Reduced−388,505 | |
| Crinetics Pharmaceuticals in | COM | 22663K107 | 9.0 | 1.2% | 239,440 | New+239,440 | |
| Livanova plc | SHS | G5509L101 | 8.8 | 1.2% | 107,373 | New+107,373 | |
| Black Diamond Therapeutics IBDTX | COM | 09203E105 | 3.1 | 0.4% | 1,674,999 | New+1,674,999 | |
| Mereo Biopharma Group plcMREO | SPON ADS | 589492107 | 2.4 | 0.3% | 7,558,756 | Unchanged |
Sold out: 12 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Align Technology IncALGN | COM | 016255101 | 0.0 | 0.0% | 0 | Sold out−67,332 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−51,895 | |
| Becton Dickinson & CoBDX | COM | 075887109 | 0.0 | 0.0% | 0 | Sold out−279,210 | |
| Biogen IncBIIB | COM | 09062X103 | 0.0 | 0.0% | 0 | Sold out−96,289 | |
| Biohaven Ltd | COM | G1110E107 | 0.0 | 0.0% | 0 | Sold out−315,944 | |
| Dexcom IncDXCM | COM | 252131107 | 0.0 | 0.0% | 0 | Sold out−538,762 | |
| Integer Holdings CorpITGR | COM | 45826H109 | 0.0 | 0.0% | 0 | Sold out−213,027 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 0.0 | 0.0% | 0 | Sold out−67,681 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 0.0 | 0.0% | 0 | Sold out−209,932 | |
| Nuvalent Inc | COM | 670703107 | 0.0 | 0.0% | 0 | Sold out−129,950 | |
| Schein Henry IncHSIC | COM | 806407102 | 0.0 | 0.0% | 0 | Sold out−624,037 | |
| Tandem Diabetes Care IncTNDM | COM NEW | 875372203 | 0.0 | 0.0% | 0 | Sold out−761,905 |
Source: SEC EDGAR, Form 13F-HR, accession 0002088557-26-000008 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.